Brief: MGC Pharmaceuticals Says Stephen Parker Will Replace Brett Mitchell As Interim Non-Executive Chair
30/05/2023 08:38
May 30 (Reuters) - MGC Pharmaceuticals Ltd MXC.AX :
* STEPHEN PARKER WILL REPLACE BRETT MITCHELL AS INTERIM
NON-EXECUTIVE CHAIR
Source text for Eikon: ID:nASX2nqX44
Further company coverage: MXC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Executes Global Licence For Non-Core Cannabis Genetics
Brief: Argent Biopharma Files Provisional US Patent On Immune Modulation And Longevity
Australia's Argent BioPharma rises to over 1-month high on new licence agreement
Brief: Argent Biopharma Signs NLC Licence To Expand Antiviral Portfolio
Brief: Argent Biopharma Says FDA-CVM Established Inad File For Cannepil Veterinary Program